Brain Tumor News!

Note: The comments under each article title are the opinion of our president, Al Musella, DPM,
and do not reflect official policy of the Musella Foundation!

03/10/05 Resection of brain metastases previously treated with stereotactic radiosurgery.        

03/10/05 Surgical outcomes of cerebellar tumors in children.        

03/10/05 Inotek Pharmaceuticals Announces Commencement of Enrollment in Phase 1b/2a Trial for Glioblastoma Multiforme        

03/10/05 Treatment-related myelodysplastic syndrome after temozolomide for recurrent high-grade glioma.        

03/10/05 UKT-04 trial of continuous metronomic low-dose chemotherapy with methotrexate and cyclophosphamide for recurrent glioblastoma.        

03/10/05 Limited efficacy of gene transfer in herpes simplex virus-thymidine kinase/ganciclovir gene therapy for brain tumors.        

03/04/05 Diffusion Pharmaceuticals Announces Strategic Alliance To Develop New Cancer Therapies        

03/03/05 Scorpion venom takes on tumors A protein from the poison helps deliver radioactive molecules to cancer cells.        

03/03/05 Brain tumor with dismal prognosis in infants can be cured in older children        

03/02/05 Parents face choice in treating childhood cancer        

03/01/05 Myriad Initiates Phase 1 Trial of MPC-6827 in Metastatic Brain Cancer        

02/28/05 Breaking News - FDA Clears Oncolytics Brain-Tumor Trial        

02/28/05 YM BioSciences and Oncoscience Report Response Rate of 35.3% in Pediatric Glioma - TheraCIM h-R3 (nimotuzumab) Phase II Results Presented at European High Grade Glioma Conference -        

02/28/05 Chugai Pharmaceutical's Antitumor Agent Natulan Now Available for Treating Glioma 28 Feb 2005        

02/27/05 15 Kilometer Run Benefits Brain Tumor Charities (Long Island, NY)        

02/23/05 Selective excision of metastatic brain tumors originating in the motor cortex with preservation of function.        

02/23/05 Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II study.        

02/23/05 Parathyroid Adenoma Linked to Primary CNS Tumors        

02/23/05 Phase I/II study of selective cyclooxygenase-2 inhibitor celecoxib as a radiation sensitizer in patients with unresectable brain metastases.        

---

Displaying Stories 4721 to 4740 of 7672
Previous 20           Next 20